Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sanie S. S. Sesay"'
Autor:
Sanie S S Sesay, Emanuele Giorgi, Peter J Diggle, David Schellenberg, David G Lalloo, Dianne J Terlouw
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183330 (2017)
The need for surveillance systems generating targeted, data-driven, responsive control efforts to accelerate and sustain malaria transmission reduction has been emphasized by programme managers, policy makers and scientists. Surveillance using easy-t
Externí odkaz:
https://doaj.org/article/9e78108031744aef9939aea9b808fa58
Autor:
Helena C. Maltezou, Karina A. Top, Satinder Aneja, Manoja Kumar Das, Jane Gidudu, Anju Shrestha, James M. Oleske, Beckie N. Tagbo, Ronit M. Pressler, Jo M. Wilmshurst, Jyoti Joshi, Niranjan Bhat, Merita Kucuku, Cecil D. Hahn, Janet S. Soul, Elissa G. Yozawitz, Geraldine B. Boylan, Flor M. Munoz, Serena Pellegrin, Paul T. Heath, Sanie S. S. Sesay, Michael A. Padula, Max Wiznitzer, Sonali Kochhar, Kollencheri Puthenveettil Vinayan, Lee Meller, Aung Soe
Publikováno v:
Vaccine, 37(52), 7596-7609. Elsevier
Vaccine
Vaccine
Autor:
Ingo Meyer, Sanie S. S. Sesay, Corinne Vandermeulen, Regine Rouzier, Jerzy Brzostek, Pierre Van Damme, Beatrice Astruc, Edyta Kowalska, Stephanie Pepin, Camille Salamand, Nicole Toursarkissian, Yves Donazzolo, Henryk Szymański, Geert Leroux-Roels
Publikováno v:
Human Vaccines & Immunotherapeutics
Human vaccines & immunotherapeutics
Human vaccines & immunotherapeutics
Here, we report a randomized multicenter phase III trial assessing the lot-to-lot consistency of the 2014-2015 Northern Hemisphere quadrivalent split-virion inactivated influenza vaccine (IIV4; Sanofi Pasteur) and comparing its immunogenicity and saf
Autor:
Xavier Camous, Lucian Visan, Nicolas Burdin, Sanie S. S. Sesay, Paul A. Tambyah, Michael Poidinger, Brian Abel, Ma Shwe Zin Nyunt, Anis Larbi, Crystal Tan Tze Ying, Vipin Narang, Christophe Carre, Ng Tze Pin, Nabil Bosco
Publikováno v:
Immunity & Ageing : I & A
Immunity & Ageing, Vol 15, Iss 1, Pp 1-6 (2018)
Immunity & Ageing, Vol 15, Iss 1, Pp 1-6 (2018)
Improving influenza vaccine efficacy is a priority to reduce the burden of influenza-associated morbidity and mortality. By careful selection of individuals based on health we show sustained response to influenza vaccination in older adults. Sustaini
Autor:
Emanuele Giorgi, David Schellenberg, Dianne J. Terlouw, David G. Lalloo, Sanie S. S. Sesay, Peter J. Diggle
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 8, p e0183330 (2017)
PLoS ONE, Vol 12, Iss 8, p e0183330 (2017)
BACKGROUND: The need for surveillance systems generating targeted, data-driven, responsive control efforts to accelerate and sustain malaria transmission reduction has been emphasized by programme managers, policy makers and scientists. Surveillance
Publikováno v:
Journal of the Royal Statistical Society Series A: Statistics in Society. 178:445-464
Summary Data from multiple prevalence surveys can provide information on common parameters of interest, which can therefore be estimated more precisely in a joint analysis than by separate analyses of the data from each survey. However, fitting a sin
Autor:
Bart W. Faber, Karim Traore, Odile Leroy, Abdourhamane H. Sall, Roma Chilengi, Sanie S. S. Sesay, Issa Diarra, Modibo Daou, Clemens H. M. Kocken, Drissa Coulibaly, Amadou Niangaly, Mahamadou A. Thera, Alan W. Thomas, Youssouf Tolo, M. Baby, Charles Arama, Mahamadou S Sissoko, Issaka Sagara, Egeruan B. Imoukhuede, Idrissa M. Traore, Abdoulaye K. Kone, Bourema Kouriba, Dapa A. Diallo, Ando B. Guindo, Edmond J. Remarque, Mady Sissoko, Ogobara K. Doumbo, Amagana Dolo, Ramadhani A. Noor, Ousmane B. Toure
Publikováno v:
Malaria Journal
Background The safety and immunogenicity of PfAMA1, adjuvanted with Alhydrogel® was assessed in malaria–experienced Malian adults. The malaria vaccine, PfAMA1-FVO [25-545] is a recombinant protein Pichia pastoris-expressed AMA-1 from Plasmodium fa
Autor:
Antoinette K, Tshefu, Oumar, Gaye, Kassoum, Kayentao, Ricardo, Thompson, Kirana M, Bhatt, Sanie S S, Sesay, Dorina G, Bustos, Emiliana, Tjitra, George, Bedu-Addo, Isabelle, Borghini-Fuhrer, Stephan, Duparc, Chang Sik, Shin, Lawrence, Fleckenstein, Arnaud, Demange
Publikováno v:
The Lancet. 375:1457-1467
Summary Background There is a need for new artemisinin-based combination therapies that are convenient, effective, and safe. We compared the efficacy and safety of pyronaridine-artesunate with that of artemether-lumefantrine for treatment of uncompli
Autor:
Sanie S. S. Sesay, Ahmed Khan
Publikováno v:
Maritime Studies. 14
In this article, we frame issues around food security and the Ebola epidemic in West Africa and discuss the potential contribution of interrelated factors like seafood access, bush meat consumption, and public health concerns with the recent outbreak
Autor:
Fanta Njie, Yin Bun Cheung, Majidah Adiamoh, Samuel Dunyo, Mathurin Diatta, David J. Conway, Paul Snell, Ramatoulie E Janha, Robert Walton, Paul Milligan, Davis Nwakanma, Cyrille Bisseye, Beth Temple, Fatou Joof, Sanie S. S. Sesay, Giorgio Sirugo
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 6, p e17371 (2011)
PLoS ONE, Vol 6, Iss 6, p e17371 (2011)
BackgroundChlorproguanil-dapsone (Lapdap), developed as a low-cost antimalarial, was withdrawn in 2008 after concerns about safety in G6PD deficient patients. This trial was conducted in 2004 to evaluate the safety and effectiveness of CD and compari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdfcc1cc5ff5e66c23937e762e1af26e
https://researchonline.lshtm.ac.uk/id/eprint/556/1/pone.0017371.pdf
https://researchonline.lshtm.ac.uk/id/eprint/556/1/pone.0017371.pdf